The Globe and Mail
🏢 Globe and Mail Inc. (Woodbridge)
Aug 4, 2026
· 3 min read
AI Analyzed
○ Unverifiable
View full audit trail →
Health Canada gives Moderna vaccine trial clearance for Ebola species tied to Congo outbreak
Original article ↗ 🔒 Paywalled source — limited preview availableB.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
0.00 · CENTER
ML v2 (DistilBERT)
-0.284 · LEFT
Ensemble
-0.142 · CENTER
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.086
9,234 articles tracked
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
Subscribe to see claim-by-claim verdicts and reasoning.
Article Excerpt
Health Canada gives Moderna vaccine trial clearance for Ebola species tied to Congo outbreak
REUTERS
PUBLISHED 1 HOUR AGO
UPDATED 45 MINUTES AGO
Open this photo in gallery:
Health Canada has cleared an early-stage study and the first volunteers have already received the shot, called mRNA-1469, according to Moderna.
DADO RUVIC/REUTERS
2 COMMENTS
SHARE
SAVE FOR LATER
Listen to this article
Learn more about audio
Log in or create a free account to listen to this article.
Moderna on Tuesday said it has begun its first human trial of an experimental vaccine to protect against Bundibugyo ebola…
Read full article at The Globe and Mail ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.
Analyzed by
B.I.A.S.
V.E.R.I.F.Y.
L.O.C.A.L.
quick v1 + full
Aug 4, 2026
📰
🔒 Unlock — Starter+
4 outlets covered this story
Side-by-side comparison · bias by outlet · framing analysis